We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current 0QGW market cap is 1.48B. The company's latest EPS is PLN 2.5535 and P/E is 35.79.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | |
| Total Revenue | 0 | 0 | 56.87M | 163.98M | 151.68M |
| Operating Income | -62.94M | -54.65M | -6.93M | 28.1M | 56.29M |
| Net Income | -63.74M | -55.77M | 1.9M | 23.19M | 41.27M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | |
| Total Assets | 113.55M | 78.32M | 184.24M | 186.18M | 208.25M |
| Total Liabilities | 135.13M | 155.71M | 130.92M | 109.67M | 90.48M |
| Total Equity | -21.58M | -77.39M | 53.31M | 76.51M | 117.78M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | |
| Operating | -33.76M | -35.24M | -32.91M | 38.84M | -2.33M |
| Investing | -9.16M | -3.01M | -31.28M | -16.06M | -37.98M |
| Financing | 12.47M | 12.67M | 110.51M | -17.84M | 34.49M |
| Market Cap | 1.48B |
| Price to Earnings Ratio | 35.79 |
| Price to Sales Ratio | 9.74 |
| Price to Cash Ratio | 30.89 |
| Price to Book Ratio | 12.54 |
| Dividend Yield | - |
| Shares Outstanding | 16.16M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Mabion Sa |
| Address |
ul. gen. mariana langiewicza 60 lodz 95-050 |
| Website | https://www.mabion.eu |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
